RYGB, duodenal switch show positive results in diabetes patients

11/10/2011 | Medscape (free registration)

Roux-en-Y gastric bypass was superior to nonsurgical treatment and laparoscopic adjustable gastric band surgery in terms of weight loss, mean A1C improvements and reduction in medication score for morbidly obese patients with type 2 diabetes, a study revealed. Researchers said RYGB and duodenal switch patients achieved similar weight loss and body mass index, but those who had the latter showed better A1C and diabetes medication scores and had higher diabetes resolution. The findings appear in the Annals of Surgery.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Payer Marketing
Avalere Health
Washington, DC
Chief Quality Officer
UnityPoint Clinic
Des Moines, ID
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX
The Pew Charitable Trusts
Director, Antibiotics and Innovation Project
Washington, DC
Senior Officer, Drugs and Medical Devices
The Pew Charitable Trusts
Washington, DC